Objective To investigate the influencing factors and reference ranges for thyroid function in preterm infants at the age of 7 days, with the aim of avoiding unnecessary clinical reexamination and intervention. Methods A retrospective analysis was performed for the data of 685 preterm infants from January 2020 to January 2023. According to gestational age and birth weight, they were divided into a high-risk group (gestational age <34 weeks or birth weight<2 000 g; 228 infants) and a low-risk group (gestational age ≥34 weeks and birth weight ≥2 000 g;457 infants). The influencing factors for thyroid function were analyzed, and 95% reference range was calculated. Results Gestational age, birth weight, birth season, sex, and assisted reproduction were the influencing factors for thyroid function (P<0.05). For the preterm infants in the high-risk group, the reference ranges of free triiodothyronine (FT3), free thyroxine (FT4), total triiodothyronine (TT3), total thyroxine (TT4), and thyroid stimulating hormone (TSH) were 2.79-5.40 pmol/L, 8.80-25.64 pmol/L, 0.80-2.15 nmol/L, 50.06-165.09 nmol/L, and 0.80-18.57 μIU/mL, respectively. For those in the low-risk group, the reference ranges of these indicators were 3.08-5.93 pmol/L, 11.17-26.24 pmol/L, 1.02-2.27 nmol/L, 62.90-168.95 nmol/L, and 0.69-13.70 μIU/mL, respectively. FT3, FT4, TT3, and TT4 were positively correlated with gestational age (P<0.05); FT3, FT4, TT3, and TT4 were positively correlated with birth weight (P<0.05); TSH was negatively correlated with birth weight (P<0.05). Conclusions Thyroid function in preterm infants at the age of 7 days is affected by the factors such as gestational age and birth weight, and the reference ranges of thyroid function in preterm infants at the age of 7 days should be established based on gestational age and birth weight.
Key words
Thyroid function /
Influencing factor /
Reference range /
Gestational age /
Preterm infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019: 921-923.
2 陈冰汝, 郑靖阳, 周丽. 早产儿低甲状腺素血症研究综述[J]. 中国优生与遗传杂志, 2020, 28(4): 521-526. DOI: 10.13404/j.cnki.cjbhh.2020.04.042.
3 Ares Segura S, Casano-Sancho P, Chueca Guindulain M, et al. Assessment of thyroid function in the preterm and/or very low birth weight newborn[J]. An Pediatr (Engl Ed), 2021, 95(4): 277.e1-277.e8. PMID: 34535429. DOI: 10.1016/j.anpede.2021.04.003.
4 国家卫生和计划生育委员会办公厅. 国家卫生计生委办公厅关于印发早产儿保健工作规范的通知: 国卫办妇幼发[2017]9号[EB/OL]. (2017-2-22)[2024-04-15]. http://www.nhc.gov.cn/fys/mrgzdt/201703/d5656db4e43a49ff9d14470864b0fb16.shtml.
5 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南（2020）[J]. 中华妇产科杂志, 2020, 55(4): 227-238. PMID: 32375429. DOI: 10.3760/cma.j.cn112141-20200114-00039.
6 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会, 中国妇幼保健协会妊娠合并糖尿病专业委员会. 妊娠期高血糖诊治指南（2022）［第一部分］[J]. 中华妇产科杂志, 2022, 57(1): 3-12. PMID: 37193590. DOI: 10.3760/cma.j.cn112141-20210917-00528.
7 中华医学会围产医学分会. 妊娠期铁缺乏和缺铁性贫血诊治指南[J]. 中华围产医学杂志, 2014, 17(7): 451-454. DOI: 10.3760/cma.j.issn.1007-9408.2014.07.006.
8 《妊娠和产后甲状腺疾病诊治指南》（第2版）编撰委员会, 中华医学会内分泌学分会, 中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南（第2版）[J]. 中华内分泌代谢杂志, 2019, 35(8): 636-665. DOI: 10.3760/cma.j.issn.1000-6699.2019.08.003.
9 李洋, 滕卫平, 滕晓春. 看懂甲状腺功能化验单: 甲状腺功能指标异常的临床解析[J]. 中华内分泌代谢杂志, 2020, 36(5): 448-452. DOI: 10.3760/cma.j.cn311282-20190617-00232.
10 成利花, 蔡成. 新生儿先天性甲状腺功能减退症的诊治进展[J]. 中国优生与遗传杂志, 2019, 27(11): 1286-1288. DOI: 10.13404/j.cnki.cjbhh.2019.11.003.
11 Kaluarachchi DC, Allen DB, Eickhoff JC, et al. Thyroid-stimulating hormone reference ranges for preterm infants[J]. Pediatrics, 2019, 144(2): e20190290. PMID: 31311840. DOI: 10.1542/peds.2019-0290.
12 Kaluarachchi DC, Nicksic VM, Allen DB, et al. Thyroid-stimulating hormone reference ranges for moderate-to-late preterm infants[J]. J Perinatol, 2021, 41(11): 2664-2667. PMID: 33279944. DOI: 10.1038/s41372-020-00895-6.
13 Kaluarachchi DC, Allen DB, Eickhoff JC, et al. Increased congenital hypothyroidism detection in preterm infants with serial newborn screening[J]. J Pediatr, 2019, 207: 220-225. PMID: 30579585. DOI: 10.1016/j.jpeds.2018.11.044.
14 张肖肖, 李桂芳. 早产儿高促甲状腺素血症的研究进展[J]. 临床合理用药杂志, 2020, 13(36): 178-181. DOI: 10.15887/j.cnki.13-1389/r.2020.36.075.
15 Zdraveska N, Kocova M. Thyroid function and dysfunction in preterm infants-challenges in evaluation, diagnosis and therapy[J]. Clin Endocrinol (Oxf), 2021, 95(4): 556-570. PMID: 33864279. DOI: 10.1111/cen.14481.
16 Lin X, Zheng LJ, Li HB, et al. Reference intervals for preterm thyroid function during the fifth to seventh day of life[J]. Clin Biochem, 2021, 95: 54-59. PMID: 34077759. DOI: 10.1016/j.clinbiochem.2021.05.014.
17 黄循斌, 周秋婧, 符青松, 等. 胎龄和日龄对早产儿甲状腺功能指标的影响[J]. 中国儿童保健杂志, 2021, 29(8): 910-913. DOI: 10.11852/zgetbjzz2020-2037.
18 Wang Y, Wu X, Hong K, et al. Establishment of reference intervals for thyroid hormones in premature infants beyond the first week of life using Beckman Coulter Unicel DxI 800[J]. Clin Biochem, 2019, 74: 19-23. PMID: 31499031. DOI: 10.1016/j.clinbiochem.2019.09.003.
19 赵德华, 贾晨路, 韩连书. 早产儿 低体重儿及患病儿遗传代谢病筛查共识[J]. 中国实用儿科杂志, 2020, 35(3): 180-184. DOI: 10.19538/j.ek2020030603.
20 田强, 崔曙东. 晚期早产儿甲状腺功能的动态变化及甲状腺功能减退症和延迟性促甲状腺激素升高的影响因素[J]. 中华围产医学杂志, 2021, 24(5): 360-365. DOI: 10.3760/cma.j.cn113903-20201009-01014.
21 邱玲, 王丹晨, 徐涛, 等. 性别和年龄及季节对甲状腺激素参考区间的影响[J]. 中华医学杂志, 2018, 98(20): 1582-1587. PMID: 29886649. DOI: 10.3760/cma.j.issn.0376-2491.2018.20.011.
22 Aktas ON, Gursoy T, Soysal E, et al. Thyroid hormone levels in late preterm, early term and term infants: a study with healthy neonates revealing reference values and factors affecting thyroid hormones[J]. J Pediatr Endocrinol Metab, 2017, 30(11): 1191-1196. PMID: 28988227. DOI: 10.1515/jpem-2017-0215.
23 Korevaar TI, Chaker L, Jaddoe VW, et al. Maternal and birth characteristics are determinants of offspring thyroid function[J]. J Clin Endocrinol Metab, 2016, 101(1): 206-213. PMID: 26583586. DOI: 10.1210/jc.2015-3559.
24 张骥, 李杨. 新生儿先天性甲状腺功能减低症危险因素的Meta分析[J]. 中国当代儿科杂志, 2021, 23(5): 505-512. PMID: 34020742. PMCID: PMC8140347. DOI: 10.7499/j.issn.1008-8830.2011121.
25 Zhou J, Luo J, Lin J, et al. Perinatal risk factors for congenital hypothyroidism: a retrospective cohort study performed at a tertiary hospital in China[J]. Medicine (Baltimore), 2020, 99(26): e20838. PMID: 32590776. PMCID: PMC7328952. DOI: 10.1097/MD.0000000000020838.
PDF(566 KB)
